Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis

Y Yu, Z Chen, Y Wang, Y Li, J Lu, L Cui, Z Yu… - International …, 2021 - Elsevier
Background Psoriasis is a T cell–mediated autoimmune skin disease. Accumulating
evidence has demonstrated that co-inhibitory receptors (CIRs) play a vital role in regulating …
被引用次数：17 相关文章

Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis.

Y Yu, Z Chen, Y Wang, Y Li, J Lu, L Cui… - International …, 2021 - europepmc.org
Background Psoriasis is a T cell-mediated autoimmune skin disease. Accumulating
evidence has demonstrated that co-inhibitory receptors (CIRs) play a vital role in regulating …

Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis

Y Yu, Z Chen, Y Wang, Y Li, J Lu… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Psoriasis is a T cell-mediated autoimmune skin disease. Accumulating
evidence has demonstrated that co-inhibitory receptors (CIRs) play a vital role in regulating …